---
category: news
title: "Kiromic Announces FDA IND Submission First-In-Human, AI derived Off-The-Shelf IsoMesothelin Gamma Delta CAR T-cell Therapy, 30 Days Before the End of"
excerpt: "Kiromic achieves key milestone for this first-in-human Phase 1 clinical trial with a target derived by Kiromic’s AI platform.HOUSTON--(BUSINESS WIRE)--$KRBP #IND--Kiromic Biopharma, Inc. (Nasdaq: KRBP),"
publishedDateTime: 2021-05-24T11:55:00Z
originalUrl: "https://us.acrofan.com/detail.php?number=473933"
webUrl: "https://us.acrofan.com/detail.php?number=473933"
type: article
quality: 15
heat: 15
published: false

provider:
  name: 아크로팬
  domain: acrofan.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://us.acrofan.com/news_images/2021/01/14/mark/20210114482917.jpg"
    width: 580
    height: 339
    isCached: true

related:
  - title: "Kiromic Announces Identification of Novel Targets for Allogeneic CAR Gamma Delta T-cell Therapy in Solid Tumors Utilizing Kiromic’s Proprietary Artificial Intelligence Engine"
    excerpt: "Kiromic announces Identification of Novel Targets for Allogeneic CAR Gamma Delta T-cell Therapy in Solid Tumors Utilizing Proprietary AI Engine"
    publishedDateTime: 2021-05-21T15:59:00Z
    webUrl: "https://www.businesswire.com/news/home/20210521005209/en/Kiromic-Announces-Identification-of-Novel-Targets-for-Allogeneic-CAR-Gamma-Delta-T-cell-Therapy-in-Solid-Tumors-Utilizing-Kiromic’s-Proprietary-Artificial-Intelligence-Engine"
    type: article
    provider:
      name: Business Wire
      domain: businesswire.com
    quality: 0

secured: "lgHQJ8pwRClj9xuOX73MzqlHi4RDGP8xaVIkpGZ3NUEtfdZTwZdhvmef3bW0WSVzBFny0UvJtLOPB4Q/9v0aXi2zC/x004n/rIA4UT8yoC8Ko5R1QxlFFF6D9rWopVdRtUwiHNuKpBI6IDO8awGSNd0tkaZ7GjLfkTdo3jDvIzRikDbn3XadRf85NSxcTdwm2k8FGkZUliKIAb8Mnhz4DVsaPshqPMcbAjXZxQ6RIOALJ6Y421I6xwTVWJ2H3WTptiKbh06BbKwtaMFM9m2CcTgIJyJZhEE7WB0Myec2Pd7T2+ldE5eAHM53tfntGT8LGjMi7sp5olHXBNY4bdUDfgXmB/iU/0AgYnpuF3dnkI4=;OziBePM/jPsQBqEN3BSweQ=="
---

